Pharmaceuticals
AI visibility monitoring for pharmaceutical brands
Patients, caregivers, clinicians, and payors now ask generative AI about medicines before they ever reach your website or a rep. percivo.ai monitors what the major AI tools say about your brand, measures it against your approved label, and shows brand, medical, market-access, digital, and insights teams where to act.
Why pharma needs generative engine optimization
Search is no longer a list of blue links. When someone asks “what's the best treatment for my condition” or “is this drug safe in pregnancy”, an AI answers in a single synthesized paragraph — often without citing a source. That answer shapes the patient conversation and the prescribing decision, and today most pharma teams have no visibility into it.
Generative engine optimization (GEO) — also called answer engine optimization (AEO) — is the discipline of measuring and improving what AI says. For pharma it is not a generic marketing exercise: claims must align with the approved label, content must clear MLR, off-label discussion carries regulatory consequences, and HCP framing differs fundamentally from patient framing.
The regulatory reality generic AI monitoring ignores
- Label-aligned accuracy. An AI answer is judged against your approved claims and indication — not a generic “sentiment” score.
- Off-label / label-boundary detection. When AI describes your brand for an unapproved population or indication, that is a Medical Affairs signal with verbatim evidence.
- Pharmacovigilance. AI answers and the patient forums they cite can surface adverse-event mentions that trigger PV obligations (FAERS in the US, EudraVigilance in the EU). percivo.ai detects and routes these without ever authoring medical content.
- MLR-ready outputs. Recommendations are structured to drop into Veeva PromoMats or ZINC review workflows.
What percivo.ai does for pharmaceutical teams
percivo.ai asks the questions your audiences actually ask — across patient, caregiver, HCP, and payor framings — of ChatGPT (OpenAI), Claude (Anthropic), Gemini (Google), Perplexity, and Grok (xAI), captures every answer, and scores it for visibility, sentiment, accuracy against your approved-claims library, and competitive share of voice. It then surfaces a prioritized action list for the teams who can do something about it. See how to choose a pharma platform or what percivo.ai is.
Frequently asked questions
What is GEO for pharma?
Generative engine optimization (GEO) for pharma is the practice of monitoring and improving what generative AI tools (ChatGPT, Claude, Gemini, Perplexity, Grok) say about pharmaceutical brands to patients, clinicians, caregivers, and payors. It is the AI-era successor to SEO, adapted for pharma's regulatory reality: label-aligned accuracy, off-label detection, pharmacovigilance, and MLR-ready outputs.
How is this different from generic AI brand monitoring?
Generic tools report 'we were mentioned 47% of the time.' A pharma-native platform measures accuracy against your approved label, flags off-label or label-boundary answers for Medical Affairs, detects adverse-event signals for pharmacovigilance, and produces recommendations structured for MLR review. The regulatory layer is the whole point.
Which AI tools should a pharma brand monitor?
The five that matter today are ChatGPT (OpenAI), Claude (Anthropic), Gemini (Google), Perplexity, and Grok (xAI). Each cites sources differently and gives different answers to the same question, so a serious platform monitors all of them, not just the loudest one.
Does percivo.ai handle adverse-event reporting?
percivo.ai detects potential adverse-event and special-situation mentions in AI answers and the patient forums they cite, then routes them into your existing pharmacovigilance workflow with evidentiary timestamps. It is a detection-and-routing layer — it never authors medical content or replaces your safety team.
Can percivo.ai monitor markets outside the US?
Yes. percivo.ai runs market-specific prompts in the local language and biases retrieval toward local sources, so a German prompt pulls German statutory-insurance and Fachinfo sources while a US prompt stays US.